Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_assertion type Assertion NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_head.
- NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_assertion description "[Perfusion with the ATP-sensitive K(+) channel (K(ATP)) inhibitor glibenclamide (GLIB) or the mitochondrial K(ATP) (mitoK(ATP)) inhibitor 5-hydroxydecanoate (5-HD) for 20 minutes before ischemia abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_provenance.
- NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_assertion evidence source_evidence_literature NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_provenance.
- NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_assertion SIO_000772 15256482 NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_provenance.
- NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_assertion wasDerivedFrom befree-2016 NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_provenance.
- NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_assertion wasGeneratedBy ECO_0000203 NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_provenance.